betahistine
Sign in to savethumb|260px|right|Betahistine(12mg) Betahistine, sold under the brand name Serc among others, is an anti-vertigo medication. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms. It was first registered in Europe in 1970 for the treatment of Ménière's disease, but current evidence does not support its efficacy in treating it.
Article
15 sectionsContents
- Medical uses
- Contraindications
- Adverse effects
- Digestive
- Others
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- Society and culture
- Brand names
- Availability
- United States
- See also
- References
thumb|260px|right|Betahistine(12mg) Betahistine, sold under the brand name Serc among others, is an anti-vertigo medication. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms. It was first registered in Europe in 1970 for the treatment of Ménière's disease, but current evidence does not support its efficacy in treating it.
==Medical uses== Betahistine was once believed to have some positive effects in the treatment of Ménière's disease and vertigo, but more recent evidence casts doubt on its efficacy. Studies of the use of betahistine have shown a reduction in symptoms of vertigo and, to a lesser extent, tinnitus, but conclusive evidence is lacking at present.